Piano di Sorrento, Italy

Dymalife Pharmaceutical

Pharmaceutical and supplement CDMO.

Dymalife Pharmaceutical is a 100% Italian pharmaceutical company based in Piano di Sorrento, Campania, controlled by ShedirPharma Group S.p.A., listed on the AIM segment of the Italian Stock Exchange. The company targets healthcare professionals, physicians and pharmacists, offering solutions across eleven therapeutic sectors including dermatological, cardiovascular, gastrointestinal, metabolic, neurological, respiratory and skeletal categories. The product portfolio comprises over 120 items in various dosage forms designed to optimise efficacy and safety for patients of different ages.

Dymalife manufactures medicinal specialities, dietary supplements, medical devices and cosmetics, with products supplied by certified GMP facilities. The development process involves rigorous quality control across all stages from design through to distribution, including product design, raw material procurement, manufacturing oversight and comprehensive verification by qualified professionals. The company maintains two facilities: the registered office in Piano di Sorrento and a logistics centre in Mercato San Severino, Campania.

The company holds ISO 9001 and ISO 13485 certifications. Dymalife conducts research and development in collaboration with leading Italian universities and private research institutions, resulting in proprietary formulations covered by patents including Visiopressin, Cronofibra, Frangilact, Bentericina, Peaflosin, Reduplaxin and Mevatris.

Capabilities

Supplements
TabletsCapsules

Tags

Also in Italy

Supplements — Tablets

See all in Italy →

Similar manufacturers

Also working in Supplements — Tablets